Evidence map›Paper›PMID 33758892›Full record

ArticlemedRxiv : the preprint server for health sciences2021

A Simple RT-PCR Melting temperature Assay to Rapidly Screen for Widely Circulating SARS-CoV-2 Variants.

Padmapriya Banada, Raquel Green, Sukalyani Banik, Abby Chopoorian, Deanna Streck, Robert Jones, Soumitesh Chakravorty, David Alland

Open access · greenAbstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 34 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Padmapriya BanadaPublic Health Research Institute; Center for Emerging Pathogens, Rutgers New Jersey Medical School.
Raquel GreenPublic Health Research Institute; Center for Emerging Pathogens, Rutgers New Jersey Medical School.
Sukalyani BanikPublic Health Research Institute; Center for Emerging Pathogens, Rutgers New Jersey Medical School.
Abby ChopoorianPublic Health Research Institute; Center for Emerging Pathogens, Rutgers New Jersey Medical School.
Deanna StreckInstitute of Genomic Medicine, Rutgers New Jersey Medical School, Newark, NJ.
Robert JonesCraic Computing LLC, Snohomish, WA.
Soumitesh ChakravortyPublic Health Research Institute; Center for Emerging Pathogens, Rutgers New Jersey Medical School.
David AllandPublic Health Research Institute; Center for Emerging Pathogens, Rutgers New Jersey Medical School.
Rutgers, The State University of New Jersey · USSnohomish Health District · US

Funding

TB detection in children using a novel stool-based GeneXpert assayR01AI131617 · NIAID · RBHS-NEW JERSEY MEDICAL SCHOOL · PI ALLAND, DAVID, NICOL, MARK PATRICK · 2018 to 2022
$2.9M
NIAID NIH HHS R01 AI131617
6 · The paper itself

Abstract

backgroundThe increased transmission of SARS-CoV-2 variants of concern (VOC) which originated in the United Kingdom (B.1.1.7), South Africa (B1.351), Brazil (P.1) and in United States (B.1.427/429) requires a vigorous public health response, including real time strain surveillance on a global scale. Although genome sequencing is the gold standard for identifying these VOCs, it is time consuming and expensive. Here, we describe a simple, rapid and high-throughput reverse-transcriptase PCR (RT-PCR) melting temperature (Tm) screening assay that identifies these three major VOCs.

methodsRT-PCR primers and four sloppy molecular beacon (SMB) probes were designed to amplify and detect the SARS-CoV-2 N501Y (A23063T) and E484K (G23012A) mutations and their corresponding wild type sequences. After RT-PCR, the VOCs were identified by a characteristic Tm of each SMB. Assay optimization and testing was performed with RNA from SARS-CoV-2 USA WA1/2020 (WT), a B.1.17 and a B.1.351 variant strains. The assay was then validated using clinical samples.

resultsThe limit of detection (LOD) for both the WT and variants was 4 and 10 genomic copies/reaction for the 501 and 484 codon assays, respectively. The assay was 100% sensitive and 100% specific for identifying the N501Y and E484K mutations in cultured virus and in clinical samples as confirmed by Sanger sequencing.

conclusionWe have developed an RT-PCR melt screening test for the three major VOCs which can be used to rapidly screen large numbers of patient samples providing an early warning for the emergence of these variants and a simple way to track their spread.

Indexed as

E484Kmelting temperature (Tm)N501YSARS-CoV-2screening testVariants

Identifiers

PMID33758892
PMCPMC7987051
OpenAlexW3134603408

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.